Nucleotropic doxorubicin nanoparticles decrease cancer cell viability, destroy mitochondria, induce autophagy and enhance tumour necrosis

QR Code

Nucleotropic doxorubicin nanoparticles decrease cancer cell viability, destroy mitochondria, induce autophagy and enhance tumour necrosis

Objective: Doxorubicin (Dox) is used clinically against various neoplasias, but suffers from serious side effects, and for the past three decades, this shortcoming has spurred research towards finding better drug delivery systems (DDSs) for this frontline drug. Methods: A non-targeted nucleotropic D...

Full description

Bibliographic Details
Main Authors:	Friedhuber, A., Chandolu, V., Manchun, S., Donkor, O., Sriamornsak, P., Dass, Crispin
Format:	Journal Article
Published:	Blackwell Publishing Ltd 2015
Online Access:	http://hdl.handle.net/20.500.11937/47010

Similar Items

Doxorubicin-induced death in tumour cells and cardiomyocytes: is autophagy the key to improving future clinical outcomes?
by: Tacar, O., et al.
Published: (2013)

Doxorubicin action on mitochondria: relevance to osteosarcoma therapy?
by: Armstrong, J., et al.
Published: (2015)

Cardiomyocyte apoptosis vs autophagy with prolonged doxorubicin treatment: Comparison with osteosarcoma cells
by: Tacar, O., et al.
Published: (2015)

Stability of freeze-dried pH-responsive dextrin nanogels containing doxorubicin
by: Manchun, S., et al.
Published: (2016)

Thiolated pectin–doxorubicin conjugates: Synthesis, characterization and anticancer activity studies
by: Cheewatanakornkool, K., et al.
Published: (2017)

Enhanced anti-tumor effect of pH-responsive dextrin nanogels delivering doxorubicin on colorectal cancer
by: Manchun, S., et al.
Published: (2015)

Novel pH-responsive dextrin nanogels for doxorubicin delivery to cancer cells with reduced cytotoxicity to cardiomyocytes and stem cells
by: Manchun, S., et al.
Published: (2014)

Doxorubicin: The dogma and the bone
by: Wong, J., et al.
Published: (2016)

Characterization and in vitro release studies of oral microbeads containing thiolated pectin-doxorubicin conjugates for colorectal cancer treatment
by: Cheewatanakornkool, K., et al.
Published: (2017)

Anti-Tumour Effect of a Chitosan Delivery System for Doxorubicin
by: Tan, M., et al.
Published: (2010)

Co-nanoencapsulated doxorubicin and Dz13 control osteosarcoma progression in a murine model
by: Tan, M., et al.
Published: (2013)

Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
by: Tacar, O., et al.
Published: (2013)

ROS, autophagy, mitochondria and cancer: Ras, the hidden master?
by: Bellot, G., et al.
Published: (2013)

Designing nanoemulsion templates for fabrication of dextrin nanoparticles via emulsion cross-linking technique
by: Manchun, S., et al.
Published: (2014)

Targeted therapy for cancer using pH-responsive nanocarrier systems
by: Manchun, S., et al.
Published: (2012)

Redox-responsive microbeads containing thiolated pectin-doxorubicin conjugate inhibit tumor growth and metastasis: An in vitro and in vivo study
by: Cheewatanakornkool, K., et al.
Published: (2018)

Autophagy and cancer: taking the ‘toxic’ out of cytotoxics
by: Giuliani, C., et al.
Published: (2013)

Metabolic stress and cancer: is autophagy the common denominator and a feasible target?
by: Giuliani, C., et al.
Published: (2014)

Doxorubicin, mesenchymal stem cell toxicity and antitumour activity: implications for clinical use
by: Baxter-Holland, M., et al.
Published: (2018)

Treatment of lung cancer using nanoparticle drug delivery systems
by: Chandolu, V., et al.
Published: (2013)

Cell and Molecular Biology Underpinning the Effects of PEDF on Cancers in General and Osteosarcoma in Particular
by: Chandolu, V., et al.
Published: (2012)

Ants must be destroyed
Published: (2008)

Transcriptional regulation of tumour necrosis factor-related apoptosis-inducing ligand
by: Md. Azahri, Nor Saadah, et al.
Published: (2013)

Development and molecular characterization of doxorubicin-resistant canine mammary gland tumour cells
by: Sahabi, Kabiru, et al.
Published: (2022)

Oxidised low density Lipoprotein decreases HIT-T15 pancreatic beta cells viability decrease in antioxidant activities
by: Zunika, A., et al.
Published: (2017)

Dz13: c-Jun Downregulation and Tumour Cell Death
by: Elahy, M., et al.
Published: (2011)

Methods for co-culturing tumour and endothelial cells: systems and their applications
by: Moorst, M., et al.
Published: (2011)

Personalisation: Developing or Destroying Customer Relations?
by: Fernandez, Sarah Kathryn
Published: (2008)

Value created or destroyed in mergers and acquisitions
by: Goel, Avnee
Published: (2011)

No smoke, no need to destroy 'ketum' tree
by: Abd Razak, Dzulkifli
Published: (2005)

The effects of enrofloxacin in combination of doxorubicin on cell viability in canine mammary gland tumor cells in vitro
by: Yang, Carolyn Kai-Ling
Published: (2017)

Role of Bcl-2 in tumour cell survival and implications for pharmacotherapy
by: Tomek, M., et al.
Published: (2012)

Mergers and Acquisitions: Value Created or Value Destroyed
by: Arya, Bhavna
Published: (2009)

Early morning fire destroys lecture theatre
by: New Sarawak Tribune
Published: (2012)

Increased efficacy of biologics following inhibition of autophagy in A549 lung cancer cells in bimodal treatment of doxorubicin and SAR405-loaded chitosan nanoparticles
by: Alamassi, Mohammed Numan, et al.
Published: (2023)

Biodegradable drug delivery systems for cancer therapy
by: Wong, T., et al.
Published: (2017)

Role of vitamin D metabolism in cutaneous tumour formation and progression
by: Nemazannikova, N., et al.
Published: (2013)

Genetic association study of tumour necrosis factor polymorphisms in chronic rhinosinusitis with and without nasal polyps
by: Misron, Khairunnisak
Published: (2016)

The role of mitochondria in ageing
by: Pollard, Amelia K.
Published: (2017)

The role of survivin in autophagy
by: Humphry, Nicola
Published: (2018)

Cannot write session to /tmp/vufind_sessions/sess_odkhkq0oe0bj3fa6htpo8dvojj